Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2HONG KONG

02 4Venipharm

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

HPCI India
Not Confirmed
arrow
arrow
HPCI India
Not Confirmed

Lefamulin Acetate

Brand Name : Xenleta

Dosage Form : Infusion Solution

Dosage Strength : 150mg

Packaging :

Approval Date : 27/07/2020

Application Number : 20190503000035

Regulatory Info : Approved

Registration Country : Sweden

blank

02

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Lefamulin Acetate

Brand Name : Xenleta

Dosage Form : Film Coated Tablet

Dosage Strength : 600mg

Packaging :

Approval Date : 27/07/2020

Application Number : 20190503000042

Regulatory Info : Approved

Registration Country : Sweden

blank

03

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Lefamulin

Brand Name : Xenleta

Dosage Form : Infusion Solution

Dosage Strength : 10mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

04

IPPE
Not Confirmed
arrow
arrow
IPPE
Not Confirmed

Lefamulin

Brand Name : Xenleta

Dosage Form : Film-Coated Tablet

Dosage Strength : 600mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

05

HONG KONG

Country
IPPE
Not Confirmed
arrow

HONG KONG

Country
arrow
IPPE
Not Confirmed

LEFAMULIN ACETATE

Brand Name : XENLETA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 600MG BASE

Packaging :

Approval Date : 2019-08-19

Application Number : 211672

Regulatory Info : RX

Registration Country : USA

blank

06

HONG KONG

Country
IPPE
Not Confirmed
arrow

HONG KONG

Country
arrow
IPPE
Not Confirmed

LEFAMULIN ACETATE

Brand Name : XENLETA

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : EQ 150MG BASE/15ML (EQ 10MG BASE/ML)

Packaging :

Approval Date : 2019-08-19

Application Number : 211673

Regulatory Info : RX

Registration Country : USA

blank